Standard
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis : Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis. / Grønbæk, Henning; Kazankov, Konstantin; Jessen, Niels et al.
2014. Abstract from Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, Hindsgavl Allé, 5500 Middelfart, Denmark.
Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
Harvard
Grønbæk, H, Kazankov, K, Jessen, N, Sandahl, TD, Hamilton-Dutoit, SJ, Vilstrup, H, Møller, HJ, Kreutzfeldt, M & Møller, HJ 2014, '
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis: Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis', Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, Hindsgavl Allé, 5500 Middelfart, Denmark,
05/09/2014 -
06/09/2014.
APA
Grønbæk, H., Kazankov, K., Jessen, N., Sandahl, T. D., Hamilton-Dutoit, S. J., Vilstrup, H., Møller, H. J., Kreutzfeldt, M., & Møller, HJ. (2014).
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis: Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis. Abstract from Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, Hindsgavl Allé, 5500 Middelfart, Denmark.
CBE
Grønbæk H, Kazankov K, Jessen N, Sandahl TD, Hamilton-Dutoit SJ, Vilstrup H, Møller HJ, Kreutzfeldt M, Møller HJ. 2014.
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis: Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis. Abstract from Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, Hindsgavl Allé, 5500 Middelfart, Denmark.
MLA
Grønbæk, Henning et al.
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis: Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis. Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, 05 Sept 2014, Hindsgavl Allé, 5500 Middelfart, Denmark, Conference abstract for conference, 2014.
Vancouver
Grønbæk H, Kazankov K, Jessen N, Sandahl TD, Hamilton-Dutoit SJ, Vilstrup H et al..
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis: Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis. 2014. Abstract from Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, Hindsgavl Allé, 5500 Middelfart, Denmark.
Author
Grønbæk, Henning ; Kazankov, Konstantin ; Jessen, Niels et al. /
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis : Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis. Abstract from Danish Society for Gastroenterology and Hepatology, 3. årsmøde, 5.-6. september 2014, Hindsgavl Allé, 5500 Middelfart, Denmark.
Bibtex
@conference{ac512e470a2a4a29926d75e42d16f8e1,
title = "Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis: Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis",
abstract = "Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis",
author = "Henning Gr{\o}nb{\ae}k and Konstantin Kazankov and Niels Jessen and Sandahl, {Thomas Damgaard} and Hamilton-Dutoit, {Stephen Jacques} and Hendrik Vilstrup and H.J. M{\o}ller and M Kreutzfeldt and HJ M{\o}ller",
year = "2014",
month = sep,
day = "5",
language = "English",
note = "null ; Conference date: 05-09-2014 Through 06-09-2014",
}
RIS
TY - ABST
T1 - Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis
AU - Grønbæk, Henning
AU - Kazankov, Konstantin
AU - Jessen, Niels
AU - Sandahl, Thomas Damgaard
AU - Hamilton-Dutoit, Stephen Jacques
AU - Vilstrup, Hendrik
AU - Møller, H.J.
AU - Kreutzfeldt, M
AU - Møller, HJ
PY - 2014/9/5
Y1 - 2014/9/5
N2 - Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis
AB - Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis
M3 - Conference abstract for conference
Y2 - 5 September 2014 through 6 September 2014
ER -